Announced on 1 June, Debut Biotechnology, Inc. plans to develop “the next generation of high-performing active ingredients” for beauty and personal-care products after raising $34bn in a Series B funding round led by L’Oreal SA’s venture capital fund BOLD. Debut says its fully vertically integrated capabilities make it unique in the biotech space. “Debut's proprietary Bio2Consumer platform spans ingredient discovery, cell-free, biofermentation, formulation, clinical trials and brand creation. The platform utilizes cell-free and advanced fermentation approaches such as continuous biomanufacturing to overcome the limitations of traditional methods, dramatically reducing the need for space, water, and expensive and unsustainable inputs,” according to the release.
L’Oreal Bets On Biotech; Beautycounter Launches CEO Search; NIVEA ‘Skin Out Loud’; Cosmetics News
“Cell-free biomanufacturing is not science fiction: it is here,” says L’Oreal’s Barbara Lavernos deputy chief executive officer in charge of research, innovation and technology, on the beauty giant’s investment in Debut Biotechnology, Inc. to drive development of sustainable, next-generation active ingredients for cosmetics. More news in brief.
More from Marketing & Advertising
The BBB National Programs, Inc. announces Phyllis Hurwitz Marcus, who served the FTC for nearly two decades, will take the reins of the National Advertising Division, replacing Laura Brett.
BBB National Programs’ NAD and CARU divisions jointly reviewed the social media posts of New York firm Bubble Beauty, finding the company could support claims of safety, but not efficacy, of its skin care products for children under 13.
The National Advertising Review Board, the appellate advertising body of the BBB National Programs, Inc., sides with NAD and P&G in a decision published 29 January finding pulling oil mouthwash marketer GuruNanda LLC, could not support ‘natural teeth whitening’ claim.
SBLA Beauty Inc. agrees to comply with NAD recommendations to modify certain express claims for its Eye Lift Wand that suggest the product is an alternative to medical eyelift procedures, while the firm is pleased the self-regulatory watchdog found many claims substantiated.
More from Business
L’Oréal USA has sold multi-cultural hair care brand Carol’s Daughter to an independent beauty entrepreneur with a ‘proven track record’ of acquiring and growing beauty brands, while it remains under the leadership of its founder and new President, Lisa Price.
Target’s Beauty division was its strongest business unit in fiscal 2024, nearly doubling in six years to reach $13.2bn on strong in-store presentation and digital support, the retailer says.
Estee Lauder Companies collaborates with Serpin Pharma to explore anti-inflammatory innovation and skin longevity, while L’Oréal Group celebrates the grand opening of North America Research & Innovation Center with ribbon cutting event.